Genentech Inc. History - Founding, Milestones & Growth Journey

History

Year	Detail
1976	Established Genentech Inc.
1985	Launched Protropin.
1993	Launched ACTIVASE.
1997	Launched Rituxan.
1998	Launched Herceptin.
2000	Launched TNKase.
2004	Launched AVASTIN & Tarceva.
2009	Merged with F. Hoffmann-La Roche Ltd.
2012	Launched PERJETA.
2015	Launched COTELLIC.
2017	Launched OCREVUS.
2019	Launched POLIVY.
2020	Launched PHESGO.
2021	Launched SUSCImo.
2022	Launched LUNSImio.

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.